Micro-X Ltd MX1
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.42
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Micro-X Ltd operates in the medical industry. The company is engaged in the design, development, manufacturing, and sale of ultra-lightweight carbon nanotube-based X-ray products, including core X-ray tubes and high-voltage generator components, for the healthcare, defense, and security markets. Its products include Nano; Rover and Mobile Backscatter Imager (MBI), Mobile Baggage Scanner (MBS), and others. Geographically, it derives a majority of its revenue from the United States and also has a presence in Asia-Pacific, and Europe & EMEA.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.micro-x.com
Valuation
|
Metric
|
MX1
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.85 |
Price/Sales | 2.42 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MX1
|
|---|---|
Quick Ratio | 0.88 |
Current Ratio | 2.06 |
Interest Coverage | — |
Quick Ratio
MX1
Profitability
|
Metric
|
MX1
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
MX1
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Lfxknmzm | Rnkgnn | $195.9 Bil | |||
| Stryker Corp
SYK
| Hlfbkpgghq | Nsqt | $137.0 Bil | |||
| Boston Scientific Corp
BSX
| Fytfhqql | Dzpqrw | $123.0 Bil | |||
| Medtronic PLC
MDT
| Fxwctvfkf | Gppmyp | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Bzwthfrl | Dntyfk | $39.4 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Clqdg | Gkls | $29.1 Bil | |||
| DexCom Inc
DXCM
| Thmbpgnjnx | Twbrf | $26.7 Bil | |||
| Steris PLC
STE
| Snzrqfmx | Zsycwd | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Cbgmmbrzds | Xlmk | $21.7 Bil | |||
| Insulet Corp
PODD
| Xlpzjxgx | Pqpkq | $16.7 Bil |
United States